FOLH1 and posterior cortical atrophy: Currently, researchers have developed PET targeting PSMA, and numerous studies have demonstrated that compared with traditional imaging methods, it not only has a higher tumor DR in recurrent PCa, but also has a higher diagnostic efficacy in LN staging of advanced PCa.